-
EP3325633
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3325633
| EP3325633 - RECOMBINANT VECTORS COMPRISING 2A PEPTIDE [Right-click to bookmark this link] | Status | The application has been withdrawn Status updated on 12.06.2020 Database last updated on 02.11.2024 | |
| Former | Request for examination was made Status updated on 27.04.2018 | ||
| Former | The international publication has been made Status updated on 11.03.2017 | Most recent event Tooltip | 12.06.2020 | Withdrawal of application | published on 15.07.2020 [2020/29] | Applicant(s) | For all designated states Tocagen Inc. 3030 Bunker Hill Street Suite 230 San Diego, CA 92109 / US | [2018/22] | Inventor(s) | 01 /
JOLLY, Douglas, J. 382 Sunset Drive Encinitas, CA 92024 / US | 02 /
LIN, Amy, H. 5488 Sonoma Place San Diego, CA 92130 / US | 03 /
HOFACRE, Andrew 24942 Rancho Clemente Laguna Niguel, CA 92677 / US | 04 /
OSTERTAG, Derek G. 6156 Blue Dawn Trail San Diego, California 92130 / US | 05 /
HOGAN, Daniel J. 7712 Parma Lane San Diego, California 92126 / US | [2018/22] | Representative(s) | Daniels, Jeffrey Nicholas Page White & Farrer Limited Bedford House 21A John Street London WC1N 2BF / GB | [N/P] |
| Former [2018/22] | Daniels, Jeffrey Nicholas Page White & Farrer Bedford House John Street London WC1N 2BF / GB | Application number, filing date | 16842998.3 | 01.09.2016 | [2018/22] | WO2016US49947 | Priority number, date | US201562214884P | 04.09.2015 Original published format: US 201562214884 P | [2018/22] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2017040815 | Date: | 09.03.2017 | Language: | EN | [2017/10] | Type: | A1 Application with search report | No.: | EP3325633 | Date: | 30.05.2018 | Language: | EN | The application published by WIPO in one of the EPO official languages on 09.03.2017 takes the place of the publication of the European patent application. | [2018/22] | Search report(s) | International search report - published on: | US | 09.03.2017 | (Supplementary) European search report - dispatched on: | EP | 14.12.2018 | Classification | IPC: | C12N15/867, C12N7/01, A61P35/00 | [2018/22] | CPC: |
C12N15/86 (EP,KR,US);
A61K48/005 (EP,KR,US);
A61P35/00 (EP,US);
C07K14/535 (US);
C07K14/57 (KR);
C07K14/70507 (US);
C07K16/2827 (EP,KR,US);
C12N15/1138 (EP,KR,US);
C12N9/78 (KR);
A61K48/00 (US);
C07K2317/76 (EP,US);
C07K2319/30 (EP,US);
C07K2319/50 (EP,KR,US);
C07K2319/60 (EP,US);
C07K2319/75 (EP,US);
C12N2310/141 (EP,KR,US);
C12N2740/13021 (US);
C12N2740/13022 (EP,KR,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/22] | Title | German: | REKOMBINANTE VEKTOREN MIT 2A-PEPTID | [2018/22] | English: | RECOMBINANT VECTORS COMPRISING 2A PEPTIDE | [2018/22] | French: | VECTEURS DE RECOMBINAISON COMPRENANT UN PEPTIDE 2A | [2018/22] | Entry into regional phase | 20.02.2018 | National basic fee paid | 20.02.2018 | Search fee paid | 20.02.2018 | Designation fee(s) paid | 20.02.2018 | Examination fee paid | Examination procedure | 20.02.2018 | Examination requested [2018/22] | 20.02.2018 | Date on which the examining division has become responsible | 18.07.2019 | Amendment by applicant (claims and/or description) | 05.06.2020 | Application withdrawn by applicant [2020/29] | Fees paid | Renewal fee | 27.09.2018 | Renewal fee patent year 03 | 27.09.2019 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y]WO2014066700 (TOCAGEN INC [US]) [Y] 1-16 * abstract * * paragraphs [0007] , [0 10] , [0 12] , [0 14] , [0 52] , [0 65] , [0 66] , [0 72] * * figure 8 *; | [Y] - OMAR D PEREZ ET AL, "Design and Selection of Toca 511 for Clinical Use: Modified Retroviral Replicating Vector With Improved Stability and Gene Expression", MOLECULAR THERAPY, (20120501), vol. 20, no. 9, doi:10.1038/mt.2012.83, ISSN 1525-0016, pages 1689 - 1698, XP055077731 [Y] 1-7,9,13-16 * abstract * * page 1690 * * figures 1, 4 * DOI: http://dx.doi.org/10.1038/mt.2012.83 | [Y] - JIN HEE KIM ET AL, "High Cleavage Efficiency of a 2A Peptide Derived from Porcine Teschovirus-1 in Human Cell Lines, Zebrafish and Mice", PLOS ONE, (20110429), vol. 6, no. 4, doi:10.1371/journal.pone.0018556, page e18556, XP055175691 [Y] 1-16 * abstract * * page 2, column 1, paragraph 3 * * page 5, column 2 - page 7, column 1, paragraph 1 * DOI: http://dx.doi.org/10.1371/journal.pone.0018556 | [Y] - S YANG ET AL, "Development of optimal bicistronic lentiviral vectors facilitates high-level TCR gene expression and robust tumor cell recognition", GENE THERAPY, (20080522), vol. 15, no. 21, doi:10.1038/gt.2008.90, ISSN 0969-7128, pages 1411 - 1423, XP055035564 [Y] 1-16 * abstract * * page 2, paragraphs 3, 4 * DOI: http://dx.doi.org/10.1038/gt.2008.90 | International search | [YA]US2012028821 (JAENISCH RUDOLF [US], et al) [Y] 1-6, 9/(1-5), 10, 13-18, 25 -42, 45-46 * . Especially para [0146], [0147], [0151], sheet 13 Fig 13A, SEQ ID NO: 35 * [A] 51-54; | [YA]WO2014066700 (TOCAGEN INC [US]) [Y] 1-5, 9/(1-5), 10, 13-18, 25 -42, 45-46 * . Especially para [0007], [0011], [0014], [0058], [0072]; claims 2-4, 42-44; SEQ ID NO: 22 * [A] 51-54; | [A] - BIENIASZ., "Intrinsic immunity: a front-line defense against viral attack.", Nat Immunol, (20041100), vol. 5, no. 11, pages 1109 - 1115, XP055373123 [A] 51-54 * . Especially pg 1112 col 1 para 2. * DOI: http://dx.doi.org/10.1038/ni1125 |